Index 
 Previous 
 Next 
 Full text 
Procedure : 2018/2775(RSP)
Document stages in plenary
Document selected : B8-0071/2019

Texts tabled :

B8-0071/2019

Debates :

PV 12/02/2019 - 24
CRE 12/02/2019 - 24

Votes :

PV 13/02/2019 - 16.11
CRE 13/02/2019 - 16.11
Explanations of votes

Texts adopted :

P8_TA(2019)0113

Minutes
Wednesday, 13 February 2019 - StrasbourgFinal edition

16.11. Use of cannabis for medicinal purposes (vote)
CRE

Motion for a resolution B8-0071/2019

(Simple majority)
(Voting record: 'Results of votes', Item 27)

MOTION FOR A RESOLUTION

Adopted (P8_TA(2019)0113)

The following had spoken:

Luke Ming Flanagan to table an oral amendment to Amendment 11 and Dubravka Šuica, on behalf of the PPE Group, on the oral amendment.

As more than 40 Members objected to the oral amendment, it was not incorporated.

Last updated: 12 June 2019Legal notice